Androgens - Therapeutic use
Research News and Information

Sunday, November 22, 2009

The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.

29 Jun 2009 BACKGROUND: Previous studies specifically focused on the immunosuppressive therapy (IST) of children with moderate aplastic anemia (MAA) are rare. The aim of this study was to evaluate the advantage of using antithymocyte globulin (ATG) in the IST ... Read more...

Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.

24 Jun 2009 Androgens have been used in the treatment of bone marrow failure syndromes without a clear understanding of their mechanism of action. Blood counts of patients with dyskeratosis congenita or aplastic anemia with mutations in telomerase genes can ... Read more...

Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.

30 May 2009 Mid-life onset male dysthymic disorder (DD) seems to be a distinct clinical condition with limited therapeutic options. Testosterone replacement is mood-enhancing and has been proposed as an antidepressant therapy, though this strategy has received ... Read more...

Latest indexed articles for 'Androgens - Therapeutic use'

These are the very latest articles for this heading:

• The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia. 29 Jun 2009
• Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. 24 Jun 2009
• The role of testosterone in women. 30 May 2009
• Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial. 30 May 2009
• Usefulness of abdominal ultrasonography in the follow-up of patients with hereditary C1-inhibitor deficiency. 30 May 2009
• Androgen therapy for delayed male puberty. 30 May 2009
• Temporal trends in testosterone levels and treatment in older men. 30 May 2009
• Current world literature. 30 May 2009
• Androgens and ageing of the skin. 30 May 2009
• Androgens and Alzheimer's disease. 30 May 2009
• The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. 29 May 2009
• Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. 11 May 2009
• The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression. 10 May 2009
• Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs? 4 May 2009
• The effects of oestrogen on urogenital health. 30 Apr 2009
• Does chemotherapy have a role before hormone-resistant disease develops? 29 Apr 2009
• When is prophylaxis for hereditary angioedema necessary? 29 Apr 2009
• Where are my testes? 9 Apr 2009
• [Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases] 5 Apr 2009
• Sex hormone augmentation as an adjunctive treatment in schizophrenia. 30 Mar 2009

See a longer list of these articles.

Technical information about 'Androgens'

Definition: Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.

Registry Number: 0

Descriptor UI: D000728

Alternative terms: Androgens; Androgenic Agents; Agents, Androgenic; Androgenic Compounds; Compounds, Androgenic;

Related Mesh Headings: Androgen Antagonists; Receptors, Androgen;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.399.472.161;

History Note: 1963

Technical Notes: /defic: consider also HYPOGONADISM & other gonadal disord in Cat C19